Literature DB >> 29318579

Evaluation of ICAM-1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis.

Aline L Bressan1, Bruna L S Picciani2, Luna Azulay-Abulafia1, Anna K Fausto-Silva2, Paula N Almeida2, Karin S G Cunha2, Eliane P Dias2, Sueli Carneiro1,3.   

Abstract

BACKGROUND: Psoriasis is a chronic inflammatory disease. Pustular, erythrodermic, and extensive plaque psoriasis are responsible for systemic complications. Systemic capillary leak syndrome is the complication with greater progression to death and occurs due to vascular changes.
PURPOSE: The aim of this study was to evaluate vascular changes through the expression of CD34 and ICAM-1 in plaque, pustular, and erythrodermic psoriasis.
METHODS: The sample consisted of seven patients with erythrodermic psoriasis, 24 with moderate-severe plaque psoriasis, 14 with mild plaque psoriasis and 13 with pustular psoriasis. Patients were submitted to physical examination and skin biopsy for histopathological examination and immunohistochemical analysis with anti-CD34 and anti-ICAM-1 antibodies. Subsequently, tissue fragments were organized by groups using the Tissue Macroarray (TMA) technique to perform immunohistochemistry.
RESULTS: In 58 patients, analysis of vessels using anti-CD34 demonstrated vascular immunostaining in superficial dermis and between dermal papillae. There were more blood vessels in erythrodermic psoriasis, followed by plaque psoriasis. In erythrodermic psoriasis, there were small and few tortuous blood vessels with great dilatation, while plaque psoriasis presented larger vessels that were less dilated and more tortuous. There was an intense and localized expression of ICAM-1 in endothelial and lymphocytic cells in all groups, with significant differences.
CONCLUSIONS: Vascular alterations are important in psoriasis, with an increase in the number of blood vessels and ICAM-1 overexpression, especially in erythrodermic form. Therefore, vascular changes and the expression of intercellular adhesion molecules could help to diagnose the erythrodermic form of psoriasis.
© 2018 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29318579     DOI: 10.1111/ijd.13883

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline.

Authors:  Audrey Bui; Jared Liu; Julie Hong; Edward Hadeler; Megan Mosca; Nicholas Brownstone; Wilson Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2021-06-21

2.  Investigation on the Mechanism of Qubi Formula in Treating Psoriasis Based on Network Pharmacology.

Authors:  Lin Zhou; Lingyun Zhang; Disheng Tao
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-21       Impact factor: 2.629

Review 3.  Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors:  Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

4.  Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis.

Authors:  Guilherme Gomes Teixeira; Naiara Lourenço Mari; Jaqueline Costa Castardo de Paula; Camila Cataldi de Alcantara; Tamires Flauzino; Marcell Alysson Batisti Lozovoy; Ligia Márcia Mário Martin; Edna Maria Vissoci Reiche; Michael Maes; Isaias Dichi; Andréa Name Colado Simão
Journal:  Clin Exp Med       Date:  2019-11-22       Impact factor: 3.984

5.  Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Authors:  Yang Lo; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

6.  Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis.

Authors:  Lamya Noure; Kirley Küçük; Sylvain Raoul Simeni Njonnou; Véronique Del Marmol; Jonathan M White; Benjamin Bondue
Journal:  Case Rep Dermatol       Date:  2021-02-04

Review 7.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837

8.  Evaluation of the Th17 pathway in psoriasis and geographic tongue.

Authors:  Bruna Lavinas Sayed Picciani; Tábata Alves Domingos; Thays Teixeira-Souza; Anna Karoline Fausto-Silva; Eliane Pedra Dias; Sueli Carneiro
Journal:  An Bras Dermatol       Date:  2019-10-24       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.